183 related articles for article (PubMed ID: 1538580)
21. Effects of n-3 polyunsaturated fatty acids on left ventricular function and functional capacity in patients with dilated cardiomyopathy.
Nodari S; Triggiani M; Campia U; Manerba A; Milesi G; Cesana BM; Gheorghiade M; Dei Cas L
J Am Coll Cardiol; 2011 Feb; 57(7):870-9. PubMed ID: 21215550
[TBL] [Abstract][Full Text] [Related]
22. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebo-controlled study.
Berman M; Erman A; Ben-Gal T; Dvir D; Georghiou GP; Stamler A; Vered Y; Vidne BA; Aravot D
Clin Cardiol; 2004 May; 27(5):295-9. PubMed ID: 15188947
[TBL] [Abstract][Full Text] [Related]
23. Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
Bristow MR; O'Connell JB; Gilbert EM; French WJ; Leatherman G; Kantrowitz NE; Orie J; Smucker ML; Marshall G; Kelly P
Circulation; 1994 Apr; 89(4):1632-42. PubMed ID: 7908610
[TBL] [Abstract][Full Text] [Related]
24. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy.
Woodley SL; Gilbert EM; Anderson JL; O'Connell JB; Deitchman D; Yanowitz FG; Mealey PC; Volkman K; Renlund DG; Menlove R
Circulation; 1991 Dec; 84(6):2426-41. PubMed ID: 1683602
[TBL] [Abstract][Full Text] [Related]
25. Effective and safe therapy with coenzyme Q10 for cardiomyopathy.
Langsjoen PH; Folkers K; Lyson K; Muratsu K; Lyson T; Langsjoen P
Klin Wochenschr; 1988 Jul; 66(13):583-90. PubMed ID: 3062263
[TBL] [Abstract][Full Text] [Related]
26. Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials.
Soja AM; Mortensen SA
Mol Aspects Med; 1997; 18 Suppl():S159-68. PubMed ID: 9266518
[TBL] [Abstract][Full Text] [Related]
27. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
Salles JE; Moisés VA; Almeida DR; Chacra AR; Moisés RS
Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379
[TBL] [Abstract][Full Text] [Related]
28. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP;
JACC Heart Fail; 2014 Dec; 2(6):641-9. PubMed ID: 25282031
[TBL] [Abstract][Full Text] [Related]
29. Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.
Ghio S; Recusani F; Klersy C; Sebastiani R; Laudisa ML; Campana C; Gavazzi A; Tavazzi L
Am J Cardiol; 2000 Apr; 85(7):837-42. PubMed ID: 10758923
[TBL] [Abstract][Full Text] [Related]
30. Effective treatment with coenzyme Q10 of patients with chronic myocardial disease.
Langsjoen PH; Vadhanavikit S; Folkers K
Drugs Exp Clin Res; 1985; 11(8):577-9. PubMed ID: 3836875
[TBL] [Abstract][Full Text] [Related]
31. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure.
Langsjoen PH
J Am Coll Cardiol; 2000 Mar; 35(3):816-7. PubMed ID: 10716489
[No Abstract] [Full Text] [Related]
32. Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy.
Griffin BP; Shah PK; Ferguson J; Rubin SA
Am J Cardiol; 1991 Apr; 67(9):848-53. PubMed ID: 1901438
[TBL] [Abstract][Full Text] [Related]
33. Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Juillière Y; Feldmann L; Perrin O; Berder V; Danchin N; Cherrier F
Int J Cardiol; 1995 Nov; 52(1):17-22. PubMed ID: 8707430
[TBL] [Abstract][Full Text] [Related]
34. [The chronic effect of coenzyme Q10 in dilated cardiomyopathy: echocardiographic assessment].
Nakanishi M; Yokota Y; Fukuzaki H
Kokyu To Junkan; 1988 Jun; 36(6):655-60. PubMed ID: 3217604
[No Abstract] [Full Text] [Related]
35. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study.
Morisco C; Trimarco B; Condorelli M
Clin Investig; 1993; 71(8 Suppl):S134-6. PubMed ID: 8241697
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.
Lei L; Liu Y
BMC Cardiovasc Disord; 2017 Jul; 17(1):196. PubMed ID: 28738783
[TBL] [Abstract][Full Text] [Related]
37. The role of coenzyme Q10 in heart failure.
Weant KA; Smith KM
Ann Pharmacother; 2005 Sep; 39(9):1522-6. PubMed ID: 16046484
[TBL] [Abstract][Full Text] [Related]
38. Usefulness of coenzyme Q10 in clinical cardiology: a long-term study.
Langsjoen H; Langsjoen P; Langsjoen P; Willis R; Folkers K
Mol Aspects Med; 1994; 15 Suppl():s165-75. PubMed ID: 7752828
[TBL] [Abstract][Full Text] [Related]
39. Noninvasive evaluation of systolic and diastolic function in severe congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.
Rahko PS; Shaver JA; Salerni R; Uretsky BF
Am J Cardiol; 1986 Jun; 57(15):1315-22. PubMed ID: 3717032
[TBL] [Abstract][Full Text] [Related]
40. Results of the multicenter spaniel trial (MUST): taurine- and carnitine-responsive dilated cardiomyopathy in American cocker spaniels with decreased plasma taurine concentration.
Kittleson MD; Keene B; Pion PD; Loyer CG
J Vet Intern Med; 1997; 11(4):204-11. PubMed ID: 9298474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
